1.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 03/2007, NCT00719017
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000521447; P06.031, CKTO-2006-04, ISRCTN14387080, P06.031-PORTEC-3, 2007-004917-33, CKTO-PORTEC-3, EU-20664, NCT00411138
|
|
3.
|
Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: SARC-GYN1, NCT00162721
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0249, GOG-0249, NCT00807768
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TOTEM, NCT00916708
|
|
8.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and older Sponsor: NCI Protocol IDs: GOG-0258, GOG-0258, NCT00942357
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
|
|
10.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789
|
|
12.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 16 and over Sponsor: Other Protocol IDs: PPS-MERT-01, NCT01509313
|
|
13.
|
Phase: Phase III Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: TOMOGYN - 1105, NCT01641497
|
|
14.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000738944, RTOG-1203, NCT01672892
|
|
15.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
|
|
16.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-20025/20288, NCT01580696
|
|
17.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 12 and over Sponsor: Other Protocol IDs: 2010-0700, NCT01590069
|
|
18.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ISS22810034, NCT01650376
|
|
19.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UTHSC-MS-96205, NCI-V97-1356, NCT00003135
|
|
20.
|
Phase: Phase II Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: KGOG2001, NCT00373620
|
|
21.
|
Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: NCI Protocol IDs: GOG-0238, GOG-0238, NCT00492778
|
|
22.
|
Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: IOSI-RO0402, RO0402, NCT00637637
|
|
23.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EndoRT, WIRB PRO NUM: 20050247, NCT00285415
|
|
24.
|
Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GRID, NCT00765570
|
|
25.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CRAD001C24114, EUDRACT- Nr. 2007-005294-60, NCT00767819
|